Results of shareholder votes disclosed under 8-K Item 5.07.
OGE ENERGY CORP. shareholders rejected Shareholder proposal regarding simple majority vote at the 2024-05-16 meeting.
“The shareholder proposal regarding simple majority vote received 69 percent of the votes cast, but only 49 percent of the outstanding votes, which is well below 80 percent of the outstanding votes required to implement the changes.”
OGE ENERGY CORP. shareholders approved Advisory vote to approve named executive officer compensation at the 2024-05-16 meeting.
“Approved, on an advisory basis, the compensation paid to named executive officers;”
OGE ENERGY CORP. shareholders approved Ratification of the appointment of Ernst & Young LLP as principal independent accountants for 2024 at the 2024-05-16 meeting.
“Ratified the appointment of Ernst & Young LLP as OGE Energy's principal independent accountants for 2024;”
UNITED FIRE GROUP INC shareholders approved Shareholder advisory vote to approve the compensation of the Company’s named executive officers at the 2024-05-15 meeting.
“Proposal 3: Shareholder advisory vote to approve the compensation of the Company’s named executive officers. Number of Shares Shares For Shares Against Shares Abstained Broker Non-Votes 20,644,827 565,004 20,642 1,281,312”
UNITED FIRE GROUP INC shareholders approved Ratify the Audit Committee's appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2024 at the 2024-05-15 meeting.
“Proposal 2: Ratify the Audit Committee's appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2024. Number of Shares Shares For Shares Against Shares Abstained Broker Non-Votes 21,717,739 723,855 70,190 —”
UNITED FIRE GROUP INC shareholders approved Elect four Class C Directors to serve three-year terms expiring in 2027 at the 2024-05-15 meeting.
“On May 15, 2024, United Fire Group, Inc. ( the "Company") held its 2024 Annual Meeting of Shareholders (the "Annual Meeting") . Each of the director nominees were elected and all the other proposals submitted to the Company's shareholders were approved. The following are the final voting results for each proposal presented at the Annual Meeting. Proposal 1: Elect four Class C Directors to serve three-year terms expiring in 2027.”
CSG SYSTEMS INTERNATIONAL INC shareholders approved Ratification of the Appointment of KPMG LLP as the Independent Registered Public Accounting Firm for Fiscal 2024 at the 2024-05-15 meeting.
“Proposal 3: Ratification of the Appointment of KPMG LLP as the Independent Registered Public Accounting Firm for Fiscal 2024. The table below shows the results of the stockholders’ vote for the ratification of the appointment of KPMG LLP as CSG’s independent registered public accounting firm for fiscal 2024: For Against Abstain 26,347,966 (98.3%) 452,808 (1.7%) 21,947”
CSG SYSTEMS INTERNATIONAL INC shareholders approved Advisory Vote to Approve the Compensation of CSG's Named Executive Officers at the 2024-05-15 meeting.
“Proposal 2: Advisory Vote to Approve the Compensation of CSG's Named Executive Officers (“NEOs”). The table below shows the results of the stockholders’ non-binding advisory vote on the compensation of CSG’s NEOs: For Against Abstain Non-Votes 24,262,670 (97.5%) 628,392 (2.5%) 52,857 1,878,802”
CSG SYSTEMS INTERNATIONAL INC shareholders approved Election of the Class III Directors at the 2024-05-15 meeting.
“Proposal 1: Election of Directors. The table below shows the results of the stockholders’ vote for the election of the Class III Directors, with terms expiring in 2027: Name of Director For Against Abstain Non-Votes Brian Shepherd 24,567,881 (98.6%) 338,897 (1.4%) 37,141 1,878,802 Silvio Tavares 24,365,057 (97.8%) 553,502 (2.2%) 25,360 1,878,802 Tse Li “Lily” Yang 24,553,890 (98.5%) 367,107 (1.5%) 22,922 1,878,802”
SOCKET MOBILE, INC. shareholders approved Ratification of Sadler, Gibb & Associates LLC as Independent Public Accountants for Fiscal Year 2023 at the 2024-05-15 meeting.
“Item 4. Ratification of Sadler, Gibb & Associates LLC as Independent Public Accountants for Fiscal Year 2023 Votes Abstained Outcome 4,775,580 453,668 200,477 Approved with an affirmative vote of 88.0% of votes cast”
SOCKET MOBILE, INC. shareholders approved Amendment to the 2004 Equity Incentive Plan to provide for a one-time stock option exchange program at the 2024-05-15 meeting.
“Item 3. Amendment to the 2004 Equity Incentive Plan to provide for a one-time stock option exchange program Votes Abstained Outcome 3,105,671 567,179 90,387 Approved with an affirmative vote of 82.5% of votes cast”
SOCKET MOBILE, INC. shareholders approved Advisory vote on executive compensation policies and practices as described in the annual meeting proxy at the 2024-05-15 meeting.
“Item 2. Advisory vote on executive compensation policies as described in the annual meeting proxy Votes Abstained Outcome 3,548,408 76,211 138,618 Approved with an affirmative vote of 94.3% of votes cast”
SOCKET MOBILE, INC. shareholders approved Election of five directors to serve until their respective successors are elected at the 2024-05-15 meeting.
“RESULTS OF THE STOCKHOLDER VOTE: Item 1 Election of Directors Name Votes Withheld Outcome 1. Charlie Bass 3,586,828 176,409 Elected 2. Kevin J. Mills 3,515,508 247,729 Elected 3. Bill Parnell 3,650,022 113,215 Elected 4. Ivan Lazarev 3,649,941 113,296 Elected 5. Lynn Zhao 3,538,113 224,914 Elected”
WAFD INC shareholders approved Frequency of Say on Pay Proposal at the 2024-02-13 meeting.
“the Company’s stockholders, consistent with the recommendation of the Company’s Board of Directors, expressed their preference for a Say-on-Pay Vote to be conducted every year”
SUN COMMUNITIES INC shareholders approved Proposal 3 – Ratification of Selection of Independent Registered Public Accounting Firm at the 2024-05-14 meeting.
“Shareholders ratified the selection of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024, as follows: Votes For Votes Against Abstentions 109,858,751 4,699,770 153,731”
SUN COMMUNITIES INC shareholders approved Proposal 2 – Non-binding Advisory Vote on Executive Compensation at the 2024-05-14 meeting.
“Shareholders approved the non-binding advisory vote on executive compensation, as follows: Votes For Votes Against Abstentions Broker Non-Votes 102,828,758 8,946,971 59,607 2,876,916”
SUN COMMUNITIES INC shareholders approved Proposal 1 – Election of Directors at the 2024-05-14 meeting.
“Shareholders elected ten directors to serve until the 2025 Annual Meeting of Shareholders and until their successors shall have been duly elected and qualified, or their earlier resignation or removal , as follows: Nominee Votes For Votes Against Abstentions Broker Non-Votes Tonya Allen 110,478,701 1,314,564 42,071 2,876,916 Meghan G. Baivier 97,174,491 14,618,918 41,927 2,876,916 Stephanie W. Bergeron 96,008,678 15,784,446 42,212 2,876,916 Jeff T. Blau 111,671,787 121,932 41,617 2,876,916 Jerome W. Ehlinger 111,288,454 505,420 41,462 2,876,916 Brian M. Hermelin 98,815,839 12,977,676 41,821 2,876,916 Craig A. Leupold 111,280,517 506,041 48,778 2,876,916 Clunet R. Lewis 94,785,143 16,954,124 96,069 2,876,916 Gary A. Shiffman 106,405,095 4,955,088 475,153 2,876,916 Arthur A. Weiss 110,450,205 1,343,353 41,778 2,876,916”
NN INC shareholders approved Ratification of the selection of Grant Thornton LLP as the independent registered public accounting firm for fiscal year ending December 31, 2024 at the 2024-05-14 meeting.
“The Audit Committee’s selection of Grant Thornton LLP as the Company’s registered independent public accounting firm for the fiscal year ending December 31, 2024 was ratified. The results were as follows: For Against Abstentions Broker Non-Votes 39,605,477 258,153 94,080 0”
NN INC shareholders approved Advisory (non-binding) vote on the compensation of the named executive officers at the 2024-05-14 meeting.
“The advisory (non-binding) vote on the executive compensation of the Company’s named executive officers was in favor of executive compensation. The results were as follows: For Against Abstentions Broker Non-Votes 22,685,963 3,056,809 379,525 13,835,413”
NN INC shareholders approved Adoption of the NN, Inc. Amended and Restated 2022 Omnibus Incentive Plan at the 2024-05-14 meeting.
“The adoption of the NN, Inc. Amended and Restated 2022 Omnibus Incentive Plan was ratified. The results were as follows: For Against Abstentions Broker Non-Votes 25,299,286 793,237 29,774 13,835,413”
NN INC shareholders approved Election of seven directors to serve for a term of one year at the 2024-05-14 meeting.
“Seven directors were elected to serve for a term of one year. The results were as follows: Name For Withheld Authority Broker Non-Votes Raynard D. Benvenuti 25,403,571 718,726 13,835,413 Harold C. Bevis 25,859,493 262,804 13,835,413 Christina E. Carroll 25,317,706 804,591 13,835,413 João Faria 23,791,491 2,330,806 13,835,413 Dr. Rajeev Gautam 25,277,307 844,990 13,835,413 Jeri J. Harman 24,990,854 1,131,443 13,835,413 Thomas H. Wilson, Jr. 25,518,162 604,135 13,835,413”
FULL HOUSE RESORTS INC shareholders approved Advisory approval of named executive officer compensation at the 2024-05-09 meeting.
“Proposal 3 – Stockholders approved, on an advisory basis, the Company’s named executive officer compensation as disclosed in the 2024 proxy statement”
FULL HOUSE RESORTS INC shareholders approved Ratification of appointment of Deloitte & Touche LLP as the independent registered public accounting firm for 2024 at the 2024-05-09 meeting.
“Proposal 2 – Stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for 2024”
FULL HOUSE RESORTS INC shareholders approved Election of eight directors nominated by the board of directors at the 2024-05-09 meeting.
“Proposal 1 – Stockholders elected the following eight directors nominated by the board of directors (the “Board”), to serve until the 2025 annual meeting of stockholders or until their successors are duly elected and qualified”
SERVOTRONICS INC /DE/ shareholders approved Ratification of Freed Maxick CPAs, P.C. as independent registered public accounting firm for 2024 at the 2024-05-10 meeting.
“The ratification of Freed Maxick CPAs, P.C. as the Company’s independent registered public accounting firm for the 2024 fiscal year received the affirmative vote of a majority of the votes cast and was passed. The results of the voting for this proposal were as follows: For Against Abstentions 1,705,073 45,985 437,323”
SERVOTRONICS INC /DE/ shareholders approved Advisory approval of executive compensation for 2023 at the 2024-05-10 meeting.
“The advisory approval of executive compensation for 2023 received the affirmative vote of a majority of the votes cast in a non-binding vote. The results of the voting for the advisory vote were as follows: For Against Abstentions Broker Non-Votes 1,227,644 694,722 6,751 259,264”
SERVOTRONICS INC /DE/ shareholders approved Election of Directors at the 2024-05-10 meeting.
“The following Directors were elected by the affirmative vote of a plurality of the votes cast.”
KOHLS Corp shareholders rejected Shareholder Proposal—Corporate Financial Sustainability Report at the 2024-05-15 meeting.
“Proposal 5 – Shareholder Proposal—Corporate Financial Sustainability Report The results of the voting on this proposal are as follows: For Against Abstain Broker Non-Votes 4,165,009 68,595,949 476,048 73,237,007”
KOHLS Corp shareholders approved Approval of the Kohl’s Corporation 2024 Long-Term Compensation Plan at the 2024-05-15 meeting.
“Proposal 4 – Approval of the Kohl’s Corporation 2024 Long-Term Compensation Plan The results of the voting on this proposal are as follows: For Against Abstain Broker Non-Votes 68,342,382 4,739,955 154,669 73,237,007”
KOHLS Corp shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending February 1, 2025 at the 2024-05-15 meeting.
“Proposal 3 – Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending February 1, 2025 The results of the voting on this proposal are as follows: For Against Abstain Broker Non-Votes 85,653,392 4,328,776 270,453 0”
KOHLS Corp shareholders approved Advisory Vote on the Compensation of the Company’s named executive officers at the 2024-05-15 meeting.
“Proposal 2 – Advisory Vote on the Compensation of the Company’s named executive officers The results of the voting on this proposal are as follows: For Against Abstain Broker Non-Votes 67,443,157 5,535,291 258,558 73,237,007”
KOHLS Corp shareholders approved Election of the 11 individuals nominated by the Board of Directors to serve as Directors for a one-year term and until their successors are duly elected and qualified at the 2024-05-15 meeting.
“Proposal 1 – Election of the 11 individuals nominated by the Board of Directors to serve as Directors for a one-year term and until their successors are duly elected and qualified The results of the voting on this proposal are as follows: Company Nominees For Against Abstain Broker Non-Votes Wendy Arlin 72,640,048 403,275 193,683 73,237,007 Michael J. Bender 72,154,900 883,727 198,379 73,237,007 Yael Cosset 71,524,813 1,510,337 201,857 73,237,007 Christine Day 72,339,077 698,983 198,946 73,237,007 H. Charles Floyd 71,447,829 1,590,691 198,486 73,237,007 Thomas A. Kingsbury 72,494,678 541,384 200,944 73,237,007 Robbin Mitchell 72,244,526 794,494 197,986 73,237,007 Jonas Prising 71,203,579 1,829,641 203,786 73,237,007 John E. Schlifske 69,562,699 3,468,398 205,909 73,237,007 Adrianne Shapira 71,379,128 1,660,961 196,917 73,237,007 Adolfo Villagomez 72,617,872 413,152 205,982 73,237,007”
Bausch Health Companies Inc. shareholders approved Appointment of the Independent Registered Public Accounting Firm at the 2024-05-14 meeting.
“The shareholders appointed PricewaterhouseCoopers LLP as the auditors for the Company to hold office until the close of the 2024 Annual Meeting of Shareholders and authorized the Company’s Board of Directors to fix the auditors’ remuneration. For Withheld 252,834,132 10,389,131”
Bausch Health Companies Inc. shareholders approved Advisory Vote on Executive Compensation at the 2024-05-14 meeting.
“The shareholders approved, on a non-binding advisory basis, the compensation of the Company’s Named Executive Officers as disclosed in the Compensation Discussion and Analysis section, executive compensation tables and accompanying narrative discussions contained in the Management Proxy Circular and Proxy Statement. For Against Abstain Broker Non-Votes I 78,660,733 5,195,531 8,435,696 70,931,303”
Bausch Health Companies Inc. shareholders approved Election of Directors at the 2024-05-14 meeting.
“The shareholders elected the following individuals to the Company’s Board of Directors, to serve until the close of the Company’s 2025 Annual Meeting of Shareholders, their successors are duly elected or appointed, or such director’s earlier resignation or removal: Name For Withheld Broker Non-Votes Thomas J. Appio 181,373,219 10,918,741 70,931,303 Christian A. Garcia 181,143,285 11,148,675 70,931,303 Brett M. Icahn 170,144,670 22,147,290 70,931,303 Sarah B. Kavanagh 180,316,464 11,975,496 70,931,303 Frank D. Lee 173,147,642 19,144,318 70,931,303 Steven D. Miller 177,700,669 14,591,291 70,931,303 Richard C. Mulligan, Ph.D. 175,256,854 17,035,106 70,931,303 John A. Paulson 179,422,691 12,869,269 70,931,303 Robert N. Power 173,228,670 19,063,290 70,931,303 Amy B. Wechsler, M.D. 181,626,477 10,665,483 70,931,303”
ZEBRA TECHNOLOGIES CORP shareholders approved Ratification of Appointment of Independent Auditors at the 2024-05-09 meeting.
“3. Proposal 3. Ratification of Appointment of Independent Auditors. To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent auditors of the Company’s financial statements for the year ending December 31, 2024. For Against Abstain 45,086,911 789,271 16,598”
ZEBRA TECHNOLOGIES CORP shareholders rejected Advisory Vote to Approve the Compensation of Named Executive Officers at the 2024-05-09 meeting.
“2. Proposal 2. Advisory Vote to Approve the Compensation of Named Executive Officers. Advisory vote to approve the following resolution: "Resolved, that the compensation of the Named Executive Officers of Zebra Technologies Corporation, as disclosed pursuant to Item 402 of Regulation S-K, as described in and including the Executive Summary – Compensation Discussion and Analysis, Compensation Discussion and Analysis, compensation tables and narrative discussion contained in this Proxy Statement, is approved by the stockholders of Zebra." For Against Abstain 17,101,924 25,454,747 32,170”
ZEBRA TECHNOLOGIES CORP shareholders approved Election of Three Directors at the 2024-05-09 meeting.
“1. Proposal 1. Election of Three Directors. For the election of the following persons as Class I Directors to the Board of Directors of the Company to hold office for a three-year term expiring at the 2027 Annual Meeting or until their respective successors are duly elected and qualified: Directors For Withheld Satish Dhanasekaran 40,643,858 1,944,983 Ross Manire 37,751,152 4,837,689 Kenneth Miller 41,464,467 1,124,374”
VERTEX PHARMACEUTICALS INC / MA shareholders rejected Shareholder proposal regarding a report on racial and gender pay gaps at the 2024-05-15 meeting.
“Based upon the following votes, the shareholders did not approve a shareholder proposal regarding a report on racial and gender pay gaps: For Against Abstain Non-Votes 63,865,687 157,637,997 694,435 11,540,149”
VERTEX PHARMACEUTICALS INC / MA shareholders approved Shareholder proposal regarding a special shareholder meeting improvement at the 2024-05-15 meeting.
“Based upon the following votes, the shareholders approved a shareholder proposal regarding a special shareholder meeting improvement: For Against Abstain Non-Votes 160,438,357 61,494,550 265,212 11,540,149”
VERTEX PHARMACEUTICALS INC / MA shareholders approved Advisory approval of 2023 compensation program for named executive officers at the 2024-05-15 meeting.
“Based upon the following votes, the shareholders approved, on an advisory basis, the 2023 compensation program for the Company's named executive officers: For Against Abstain Non-Votes 202,098,575 19,223,784 875,760 11,540,149”
VERTEX PHARMACEUTICALS INC / MA shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for 2024 at the 2024-05-15 meeting.
“Based upon the following votes, the shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024: For Against Abstain Non-Votes 229,460,523 3,987,619 290,126 0”
VERTEX PHARMACEUTICALS INC / MA shareholders approved Election of Suketu Upadhyay as director at the 2024-05-15 meeting.
“178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No. 2 : Based upon the following votes, the shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024: For Against Abstain Non-Votes 229,460,523 3,987,619 290,126 0 Proposal No.”
VERTEX PHARMACEUTICALS INC / MA shareholders approved Election of Nancy Thornberry as director at the 2024-05-15 meeting.
“186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.”
VERTEX PHARMACEUTICALS INC / MA shareholders approved Election of Jennifer Schneider as director at the 2024-05-15 meeting.
“6 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.”
VERTEX PHARMACEUTICALS INC / MA shareholders approved Election of Bruce Sachs as director at the 2024-05-15 meeting.
“,689 186,843 11,540,149 Reshma Kewalramani 221,328,875 695,546 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.”
VERTEX PHARMACEUTICALS INC / MA shareholders approved Election of Diana McKenzie as director at the 2024-05-15 meeting.
“,558 186,524 11,540,149 Alan Garber 220,695,587 1,315,689 186,843 11,540,149 Reshma Kewalramani 221,328,875 695,546 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.”
VERTEX PHARMACEUTICALS INC / MA shareholders approved Election of Jeffrey Leiden as director at the 2024-05-15 meeting.
“08,512 182,981 11,540,149 Lloyd Carney 213,533,037 8,478,558 186,524 11,540,149 Alan Garber 220,695,587 1,315,689 186,843 11,540,149 Reshma Kewalramani 221,328,875 695,546 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.”
VERTEX PHARMACEUTICALS INC / MA shareholders approved Election of Michel Lagarde as director at the 2024-05-15 meeting.
“gainst Abstain Non-Votes Sangeeta Bhatia 221,206,626 808,512 182,981 11,540,149 Lloyd Carney 213,533,037 8,478,558 186,524 11,540,149 Alan Garber 220,695,587 1,315,689 186,843 11,540,149 Reshma Kewalramani 221,328,875 695,546 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.”
VERTEX PHARMACEUTICALS INC / MA shareholders approved Election of Reshma Kewalramani as director at the 2024-05-15 meeting.
“nual meeting of shareholders to be held in 2025: For Against Abstain Non-Votes Sangeeta Bhatia 221,206,626 808,512 182,981 11,540,149 Lloyd Carney 213,533,037 8,478,558 186,524 11,540,149 Alan Garber 220,695,587 1,315,689 186,843 11,540,149 Reshma Kewalramani 221,328,875 695,546 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.